Avidity Biosciences Inc. News
Sarepta Updates Eteplirsen Study Results, FDA Filing Still on for Mid Year
The company presents at the J.P. Morgan Healthcare Conference on Thursday.
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
The markets are presenting a buying opportunity at current levels, but only if you know which stocks to buy, Cramer says.
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
To prep investors for 2015, a list of clinical trial read-outs and FDA events expected to have a significant impact on stock prices in the first half of next year.
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
The CEOs of Exact Sciences, Idenix Pharma, Prosensa, Agios, Bluebird Bio and InterMune vie for the coveted title of Best Biotech CEO
Jim Cramer's Five Best Stock Picks for the Biotech Sector
TheStreet's Jim Cramer has selected 12 sectors where he thinks investors should put their money. Biotech stocks have had a 'monstrous' year. Here are Cramer's best picks.
Prosensa (RNA) Highlighted As Today's Perilous Reversal Stock
Trade-Ideas LLC identified Prosensa (RNA) as a "perilous reversal" (up big yesterday but down big today) candidate
S&P 500 Little Changed Amid Uncertainty Over U.S. Economic Growth
Investors continue to celebrate stimulus measures announced by China's central bank and the European Central Bank late last week.
S&P 500 Holds at Record Highs as Global Optimism Gives Support
Stocks flirt with intraday record highs and maintain recent buoyancy as global optimism combines with seasonal cheer.
Oil Prices Bounce From 9-Month Lows As Hurricane Ian Clips Gulf Production
"Hopefully, disruptions will be very limited due to Ian, but there remain many factors driving prices both up and down across the country,” said Gasbuddy's Patrick De Haan.
Tim Cook and Apple Make a Move That Could Annoy China
iPhone maker wants to diversify its supply chain and expand in a crucial market.